Table of Contents 1 Daptomycin Market Overview 1.1 Product Overview and Scope of Daptomycin 1.2 Daptomycin Segment by Type 1.2.1 Global Daptomycin Sales Growth Rate Comparison by Type (2021-2026) 1.2.2 350 mg lyophilized powder 1.2.3 500 mg lyophilized powder 1.3 Daptomycin Segment by Application 1.3.1 Daptomycin Sales Comparison by Application: 2020 VS 2026 1.3.2 Adult 1.3.3 Pediatric patients (1 to 17 years of age) 1.4 Global Daptomycin Market Size Estimates and Forecasts 1.4.1 Global Daptomycin Revenue 2015-2026 1.4.2 Global Daptomycin Sales 2015-2026 1.4.3 Daptomycin Market Size by Region: 2020 Versus 2026 2 Global Daptomycin Market Competition by Manufacturers 2.1 Global Daptomycin Sales Market Share by Manufacturers (2015-2020) 2.2 Global Daptomycin Revenue Share by Manufacturers (2015-2020) 2.3 Global Daptomycin Average Price by Manufacturers (2015-2020) 2.4 Manufacturers Daptomycin Manufacturing Sites, Area Served, Product Type 2.5 Daptomycin Market Competitive Situation and Trends 2.5.1 Daptomycin Market Concentration Rate 2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue 2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 2.7 Primary Interviews with Key Daptomycin Players (Opinion Leaders) 3 Daptomycin Retrospective Market Scenario by Region 3.1 Global Daptomycin Retrospective Market Scenario in Sales by Region: 2015-2020 3.2 Global Daptomycin Retrospective Market Scenario in Revenue by Region: 2015-2020 3.3 North America Daptomycin Market Facts & Figures by Country 3.3.1 North America Daptomycin Sales by Country 3.3.2 North America Daptomycin Sales by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Daptomycin Market Facts & Figures by Country 3.4.1 Europe Daptomycin Sales by Country 3.4.2 Europe Daptomycin Sales by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Daptomycin Market Facts & Figures by Region 3.5.1 Asia Pacific Daptomycin Sales by Region 3.5.2 Asia Pacific Daptomycin Sales by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Daptomycin Market Facts & Figures by Country 3.6.1 Latin America Daptomycin Sales by Country 3.6.2 Latin America Daptomycin Sales by Country 3.6.3 Mexico 3.6.3 Brazil 3.6.3 Argentina 3.7 Middle East and Africa Daptomycin Market Facts & Figures by Country 3.7.1 Middle East and Africa Daptomycin Sales by Country 3.7.2 Middle East and Africa Daptomycin Sales by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global Daptomycin Historic Market Analysis by Type 4.1 Global Daptomycin Sales Market Share by Type (2015-2020) 4.2 Global Daptomycin Revenue Market Share by Type (2015-2020) 4.3 Global Daptomycin Price Market Share by Type (2015-2020) 4.4 Global Daptomycin Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End 5 Global Daptomycin Historic Market Analysis by Application 5.1 Global Daptomycin Sales Market Share by Application (2015-2020) 5.2 Global Daptomycin Revenue Market Share by Application (2015-2020) 5.3 Global Daptomycin Price by Application (2015-2020) 6 Company Profiles and Key Figures in Daptomycin Business 6.1 Merck & Co. 6.1.1 Corporation Information 6.1.2 Merck & Co. Description, Business Overview and Total Revenue 6.1.3 Merck & Co. Daptomycin Sales, Revenue and Gross Margin (2015-2020) 6.1.4 Merck & Co. Products Offered 6.1.5 Merck & Co. Recent Development 6.2 Pfizer 6.2.1 Pfizer Daptomycin Production Sites and Area Served 6.2.2 Pfizer Description, Business Overview and Total Revenue 6.2.3 Pfizer Daptomycin Sales, Revenue and Gross Margin (2015-2020) 6.2.4 Pfizer Products Offered 6.2.5 Pfizer Recent Development 6.3 Teva 6.3.1 Teva Daptomycin Production Sites and Area Served 6.3.2 Teva Description, Business Overview and Total Revenue 6.3.3 Teva Daptomycin Sales, Revenue and Gross Margin (2015-2020) 6.3.4 Teva Products Offered 6.3.5 Teva Recent Development 6.4 Mylan 6.4.1 Mylan Daptomycin Production Sites and Area Served 6.4.2 Mylan Description, Business Overview and Total Revenue 6.4.3 Mylan Daptomycin Sales, Revenue and Gross Margin (2015-2020) 6.4.4 Mylan Products Offered 6.4.5 Mylan Recent Development 6.5 Fresenius Kabi 6.5.1 Fresenius Kabi Daptomycin Production Sites and Area Served 6.5.2 Fresenius Kabi Description, Business Overview and Total Revenue 6.5.3 Fresenius Kabi Daptomycin Sales, Revenue and Gross Margin (2015-2020) 6.5.4 Fresenius Kabi Products Offered 6.5.5 Fresenius Kabi Recent Development 6.6 Sagent Pharmaceuticals 6.6.1 Sagent Pharmaceuticals Daptomycin Production Sites and Area Served 6.6.2 Sagent Pharmaceuticals Description, Business Overview and Total Revenue 6.6.3 Sagent Pharmaceuticals Daptomycin Sales, Revenue and Gross Margin (2015-2020) 6.6.4 Sagent Pharmaceuticals Products Offered 6.6.5 Sagent Pharmaceuticals Recent Development 6.7 Xellia 6.6.1 Xellia Daptomycin Production Sites and Area Served 6.6.2 Xellia Description, Business Overview and Total Revenue 6.6.3 Xellia Daptomycin Sales, Revenue and Gross Margin (2015-2020) 6.4.4 Xellia Products Offered 6.7.5 Xellia Recent Development 6.8 Hisun 6.8.1 Hisun Daptomycin Production Sites and Area Served 6.8.2 Hisun Description, Business Overview and Total Revenue 6.8.3 Hisun Daptomycin Sales, Revenue and Gross Margin (2015-2020) 6.8.4 Hisun Products Offered 6.8.5 Hisun Recent Development 6.9 HENGRUI PHARMA 6.9.1 HENGRUI PHARMA Daptomycin Production Sites and Area Served 6.9.2 HENGRUI PHARMA Description, Business Overview and Total Revenue 6.9.3 HENGRUI PHARMA Daptomycin Sales, Revenue and Gross Margin (2015-2020) 6.9.4 HENGRUI PHARMA Products Offered 6.9.5 HENGRUI PHARMA Recent Development 6.10 Huadong Medicine 6.10.1 Huadong Medicine Daptomycin Production Sites and Area Served 6.10.2 Huadong Medicine Description, Business Overview and Total Revenue 6.10.3 Huadong Medicine Daptomycin Sales, Revenue and Gross Margin (2015-2020) 6.10.4 Huadong Medicine Products Offered 6.10.5 Huadong Medicine Recent Development 7 Daptomycin Manufacturing Cost Analysis 7.1 Daptomycin Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Raw Materials Price Trend 7.1.3 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Daptomycin 7.4 Daptomycin Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Daptomycin Distributors List 8.3 Daptomycin Customers 9 Market Dynamics 9.1 Market Trends 9.2 Opportunities and Drivers 9.3 Challenges 9.4 Porter's Five Forces Analysis 10 Global Market Forecast 10.1 Global Daptomycin Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Daptomycin by Type (2021-2026) 10.1.2 Global Forecasted Revenue of Daptomycin by Type (2021-2026) 10.2 Daptomycin Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Daptomycin by Application (2021-2026) 10.2.2 Global Forecasted Revenue of Daptomycin by Application (2021-2026) 10.3 Daptomycin Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Daptomycin by Region (2021-2026) 10.3.2 Global Forecasted Revenue of Daptomycin by Region (2021-2026) 10.4 North America Daptomycin Estimates and Projections (2021-2026) 10.5 Europe Daptomycin Estimates and Projections (2021-2026) 10.6 Asia Pacific Daptomycin Estimates and Projections (2021-2026) 10.7 Latin America Daptomycin Estimates and Projections (2021-2026) 10.8 Middle East and Africa Daptomycin Estimates and Projections (2021-2026) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Daptomycin Sales (K MT) Growth Rate Comparison by Type (2015-2026) Table 2. Global Daptomycin Sales (K MT) Comparison by Application: 2020 VS 2026 Table 3. Global Daptomycin Market Size by Type (K MT) (US$ Million) (2020 VS 2026) Table 4. Global Key Daptomycin Manufacturers Covered in This Study Table 5. Global Daptomycin Sales (K MT) by Manufacturers (2015-2020) Table 6. Global Daptomycin Sales Share by Manufacturers (2015-2020) Table 7. Global Daptomycin Revenue (Million USD) by Manufacturers (2015-2020) Table 8. Global Daptomycin Revenue Share by Manufacturers (2015-2020) Table 9. Global Market Daptomycin Average Price (USD/MT) of Key Manufacturers (2015-2020) Table 10. Manufacturers Daptomycin Sales Sites and Area Served Table 11. Manufacturers Daptomycin Product Types Table 12. Global Daptomycin Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Daptomycin by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Daptomycin as of 2019) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Main Points Interviewed from Key Daptomycin Players Table 16. Global Daptomycin Sales (K MT) by Region (2015-2020) Table 17. Global Daptomycin Sales Market Share by Region (2015-2020) Table 18. Global Daptomycin Revenue (Million US$) by Region (2015-2020) Table 19. Global Daptomycin Revenue Market Share by Region (2015-2020) Table 20. North America Daptomycin Sales by Country (2015-2020) (K MT) Table 21. North America Daptomycin Sales Market Share by Country (2015-2020) Table 22. North America Daptomycin Revenue by Country (2015-2020) (US$ Million) Table 23. North America Daptomycin Revenue Market Share by Country (2015-2020) Table 24. Europe Daptomycin Sales by Country (2015-2020) (K MT) Table 25. Europe Daptomycin Sales Market Share by Country (2015-2020) Table 26. Europe Daptomycin Revenue by Country (2015-2020) (US$ Million) Table 27. Europe Daptomycin Revenue Market Share by Country (2015-2020) Table 28. Asia Pacific Daptomycin Sales by Region (2015-2020) (K MT) Table 29. Asia Pacific Daptomycin Sales Market Share by Region (2015-2020) Table 30. Asia Pacific Daptomycin Revenue by Region (2015-2020) (US$ Million) Table 31. Asia Pacific Daptomycin Revenue Market Share by Region (2015-2020) Table 32. Latin America Daptomycin Sales by Country (2015-2020) (K MT) Table 33. Latin America Daptomycin Sales Market Share by Country (2015-2020) Table 34. Latin America Daptomycin Revenue by Country (2015-2020) (US$ Million) Table 35. Latin America Daptomycin Revenue Market Share by Country (2015-2020) Table 36. Middle East and Africa Daptomycin Sales by Country (2015-2020) (K MT) Table 37. Middle East and Africa Daptomycin Sales Market Share by Country (2015-2020) Table 38. Middle East and Africa Daptomycin Revenue by Country (2015-2020) (US$ Million) Table 39. Middle East and Africa Daptomycin Revenue Market Share by Country (2015-2020) Table 40. Global Daptomycin Sales (K MT) by Type (2015-2020) Table 41. Global Daptomycin Sales Share by Type (2015-2020) Table 42. Global Daptomycin Revenue (Million US$) by Type (2015-2020) Table 43. Global Daptomycin Revenue Share by Type (2015-2020) Table 44. Global Daptomycin Price (USD/MT) by Type (2015-2020) Table 45. Global Daptomycin Sales (K MT) by Application (2015-2020) Table 46. Global Daptomycin Sales Market Share by Application (2015-2020) Table 47. Global Daptomycin Sales Growth Rate by Application (2015-2020) Table 48. Merck & Co. Daptomycin Corporation Information Table 49. Merck & Co. Description and Business Overview Table 50. Merck & Co. Daptomycin Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 51. Merck & Co. Main Product Table 52. Merck & Co. Recent Development Table 53. Pfizer Daptomycin Corporation Information Table 54. Pfizer Corporation Information Table 55. Pfizer Daptomycin Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 56. Pfizer Main Product Table 57. Pfizer Recent Development Table 58. Teva Daptomycin Corporation Information Table 59. Teva Corporation Information Table 60. Teva Daptomycin Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 61. Teva Main Product Table 62. Teva Recent Development Table 63. Mylan Daptomycin Corporation Information Table 64. Mylan Corporation Information Table 65. Mylan Daptomycin Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 66. Mylan Main Product Table 67. Mylan Recent Development Table 68. Fresenius Kabi Daptomycin Corporation Information Table 69. Fresenius Kabi Corporation Information Table 70. Fresenius Kabi Daptomycin Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 71. Fresenius Kabi Main Product Table 72. Fresenius Kabi Recent Development Table 73. Sagent Pharmaceuticals Daptomycin Corporation Information Table 74. Sagent Pharmaceuticals Corporation Information Table 75. Sagent Pharmaceuticals Daptomycin Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 76. Sagent Pharmaceuticals Main Product Table 77. Sagent Pharmaceuticals Recent Development Table 78. Xellia Daptomycin Corporation Information Table 79. Xellia Corporation Information Table 80. Xellia Daptomycin Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 81. Xellia Main Product Table 82. Xellia Recent Development Table 83. Hisun Daptomycin Corporation Information Table 84. Hisun Corporation Information Table 85. Hisun Daptomycin Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 86. Hisun Main Product Table 87. Hisun Recent Development Table 88. HENGRUI PHARMA Daptomycin Corporation Information Table 89. HENGRUI PHARMA Corporation Information Table 90. HENGRUI PHARMA Daptomycin Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 91. HENGRUI PHARMA Main Product Table 92. HENGRUI PHARMA Recent Development Table 93. Huadong Medicine Daptomycin Corporation Information Table 94. Huadong Medicine Corporation Information Table 95. Huadong Medicine Daptomycin Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 96. Huadong Medicine Main Product Table 97. Huadong Medicine Recent Development Table 98. Sales Base and Market Concentration Rate of Raw Material Table 99. Key Suppliers of Raw Materials Table 100. Daptomycin Distributors List Table 101. Daptomycin Customers List Table 102. Market Key Trends Table 103. Key Opportunities and Drivers: Impact Analysis (2021-2026) Table 104. Key Challenges Table 105. Global Daptomycin Sales (K MT) Forecast by Type (2021-2026) Table 106. Global Daptomycin Sales Market Share Forecast by Type (2021-2026) Table 107. Global Daptomycin Revenue (Million US$) Forecast by Type (2021-2026) Table 108. Global Daptomycin Revenue (Million US$) Market Share Forecast by Type (2021-2026) Table 109. Global Daptomycin Sales (K MT) Forecast by Application (2021-2026) Table 110. Global Daptomycin Revenue (Million US$) Forecast by Application (2021-2026) Table 111. Global Daptomycin Sales (K MT) Forecast by Region (2021-2026) Table 112. Global Daptomycin Sales Market Share Forecast by Region (2021-2026) Table 113. Global Daptomycin Revenue Forecast by Region (2021-2026) (US$ Million) Table 114. Global Daptomycin Revenue Market Share Forecast by Region (2021-2026) Table 115. Research Programs/Design for This Report Table 116. Key Data Information from Secondary Sources Table 117. Key Data Information from Primary Sources List of Figures Figure 1. Picture of Daptomycin Figure 2. Global Daptomycin Sales Market Share by Type: 2020 VS 2026 Figure 3. 350 mg lyophilized powder Product Picture Figure 4. 500 mg lyophilized powder Product Picture Figure 5. Global Daptomycin Consumption Market Share by Application: 2020 VS 2026 Figure 6. Adult Figure 7. Pediatric patients (1 to 17 years of age) Figure 8. Global Daptomycin Market Size 2015-2026 (US$ Million) Figure 9. Global Daptomycin Sales Capacity (K MT) (2015-2026) Figure 10. Global Daptomycin Market Size Market Share by Region: 2020 Versus 2026 Figure 11. Daptomycin Sales Share by Manufacturers in 2020 Figure 12. Global Daptomycin Revenue Share by Manufacturers in 2019 Figure 13. The Global 5 and 10 Largest Players: Market Share by Daptomycin Revenue in 2019 Figure 14. Daptomycin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 15. Global Daptomycin Sales Market Share by Region (2015-2020) Figure 16. Global Daptomycin Sales Market Share by Region in 2019 Figure 17. Global Daptomycin Revenue Market Share by Region (2015-2020) Figure 18. Global Daptomycin Revenue Market Share by Region in 2019 Figure 19. North America Daptomycin Sales Market Share by Country in 2019 Figure 20. North America Daptomycin Revenue Market Share by Country in 2019 Figure 21. U.S. Daptomycin Sales Growth Rate (2015-2020) (K MT) Figure 22. U.S. Daptomycin Revenue Growth Rate (2015-2020) (US$ Million) Figure 23. Canada Daptomycin Sales Growth Rate (2015-2020) (K MT) Figure 24. Canada Daptomycin Revenue Growth Rate (2015-2020) (US$ Million) Figure 25. Europe Daptomycin Sales Market Share by Country in 2019 Figure 26. Europe Daptomycin Revenue Market Share by Country in 2019 Figure 27. Germany Daptomycin Sales Growth Rate (2015-2020) (K MT) Figure 28. Germany Daptomycin Revenue Growth Rate (2015-2020) (US$ Million) Figure 29. France Daptomycin Sales Growth Rate (2015-2020) (K MT) Figure 30. France Daptomycin Revenue Growth Rate (2015-2020) (US$ Million) Figure 31. U.K. Daptomycin Sales Growth Rate (2015-2020) (K MT) Figure 32. U.K. Daptomycin Revenue Growth Rate (2015-2020) (US$ Million) Figure 33. Italy Daptomycin Sales Growth Rate (2015-2020) (K MT) Figure 34. Italy Daptomycin Revenue Growth Rate (2015-2020) (US$ Million) Figure 35. Russia Daptomycin Sales Growth Rate (2015-2020) (K MT) Figure 36. Russia Daptomycin Revenue Growth Rate (2015-2020) (US$ Million) Figure 37. Asia Pacific Daptomycin Sales Market Share by Region in 2019 Figure 38. Asia Pacific Daptomycin Revenue Market Share by Region in 2019 Figure 39. China Daptomycin Sales Growth Rate (2015-2020) (K MT) Figure 40. China Daptomycin Revenue Growth Rate (2015-2020) (US$ Million) Figure 41. Japan Daptomycin Sales Growth Rate (2015-2020) (K MT) Figure 42. Japan Daptomycin Revenue Growth Rate (2015-2020) (US$ Million) Figure 43. South Korea Daptomycin Sales Growth Rate (2015-2020) (K MT) Figure 44. South Korea Daptomycin Revenue Growth Rate (2015-2020) (US$ Million) Figure 45. India Daptomycin Sales Growth Rate (2015-2020) (K MT) Figure 46. India Daptomycin Revenue Growth Rate (2015-2020) (US$ Million) Figure 47. Australia Daptomycin Sales Growth Rate (2015-2020) (K MT) Figure 48. Australia Daptomycin Revenue Growth Rate (2015-2020) (US$ Million) Figure 49. Taiwan Daptomycin Sales Growth Rate (2015-2020) (K MT) Figure 50. Taiwan Daptomycin Revenue Growth Rate (2015-2020) (US$ Million) Figure 51. Indonesia Daptomycin Sales Growth Rate (2015-2020) (K MT) Figure 52. Indonesia Daptomycin Revenue Growth Rate (2015-2020) (US$ Million) Figure 53. Thailand Daptomycin Sales Growth Rate (2015-2020) (K MT) Figure 54. Thailand Daptomycin Revenue Growth Rate (2015-2020) (US$ Million) Figure 55. Malaysia Daptomycin Sales Growth Rate (2015-2020) (K MT) Figure 56. Malaysia Daptomycin Revenue Growth Rate (2015-2020) (US$ Million) Figure 57. Philippines Daptomycin Sales Growth Rate (2015-2020) (K MT) Figure 58. Philippines Daptomycin Revenue Growth Rate (2015-2020) (US$ Million) Figure 59. Vietnam Daptomycin Sales Growth Rate (2015-2020) (K MT) Figure 60. Vietnam Daptomycin Revenue Growth Rate (2015-2020) (US$ Million) Figure 61. Latin America Daptomycin Sales Market Share by Country in 2019 Figure 62. Latin America Daptomycin Revenue Market Share by Country in 2019 Figure 63. Mexico Daptomycin Sales Growth Rate (2015-2020) (K MT) Figure 64. Mexico Daptomycin Revenue Growth Rate (2015-2020) (US$ Million) Figure 65. Brazil Daptomycin Sales Growth Rate (2015-2020) (K MT) Figure 66. Brazil Daptomycin Revenue Growth Rate (2015-2020) (US$ Million) Figure 67. Argentina Daptomycin Sales Growth Rate (2015-2020) (K MT) Figure 68. Argentina Daptomycin Revenue Growth Rate (2015-2020) (US$ Million) Figure 69. Middle East and Africa Daptomycin Sales Market Share by Country in 2019 Figure 70. Middle East and Africa Daptomycin Revenue Market Share by Country in 2019 Figure 71. Turkey Daptomycin Sales Growth Rate (2015-2020) (K MT) Figure 72. Turkey Daptomycin Revenue Growth Rate (2015-2020) (US$ Million) Figure 73. Saudi Arabia Daptomycin Sales Growth Rate (2015-2020) (K MT) Figure 74. Saudi Arabia Daptomycin Revenue Growth Rate (2015-2020) (US$ Million) Figure 75. U.A.E Daptomycin Sales Growth Rate (2015-2020) (K MT) Figure 76. U.A.E Daptomycin Revenue Growth Rate (2015-2020) (US$ Million) Figure 77. Sales Market Share of Daptomycin by Type (2015-2020) Figure 78. Sales Market Share of Daptomycin by Type in 2019 Figure 79. Revenue Share of Daptomycin by Type (2015-2020) Figure 80. Revenue Market Share of Daptomycin by Type in 2019 Figure 81. Global Daptomycin Sales Growth by Type (2015-2020) (K MT) Figure 82. Global Daptomycin Sales Market Share by Application (2015-2020) Figure 83. Global Daptomycin Sales Market Share by Application in 2019 Figure 84. Global Revenue Share of Daptomycin by Application (2015-2020) Figure 85. Global Revenue Share of Daptomycin by Application in 2020 Figure 86. Merck & Co. Total Revenue (US$ Million): 2019 Compared with 2018 Figure 87. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018 Figure 88. Teva Total Revenue (US$ Million): 2019 Compared with 2018 Figure 89. Mylan Total Revenue (US$ Million): 2019 Compared with 2018 Figure 90. Fresenius Kabi Total Revenue (US$ Million): 2019 Compared with 2018 Figure 91. Sagent Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 92. Xellia Total Revenue (US$ Million): 2019 Compared with 2018 Figure 93. Hisun Total Revenue (US$ Million): 2019 Compared with 2018 Figure 94. HENGRUI PHARMA Total Revenue (US$ Million): 2019 Compared with 2018 Figure 95. Huadong Medicine Total Revenue (US$ Million): 2019 Compared with 2018 Figure 96. Price Trend of Key Raw Materials Figure 97. Manufacturing Cost Structure of Daptomycin Figure 98. Manufacturing Process Analysis of Daptomycin Figure 99. Daptomycin Industrial Chain Analysis Figure 100. Channels of Distribution Figure 101. Distributors Profiles Figure 102. Porter's Five Forces Analysis Figure 103. North America Daptomycin Sales (K MT) and Growth Rate Forecast (2021-2026) Figure 104. North America Daptomycin Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 105. Europe Daptomycin Sales (K MT) and Growth Rate Forecast (2021-2026) Figure 106. Europe Daptomycin Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 107. Latin America Daptomycin Sales (K MT) and Growth Rate Forecast (2021-2026) Figure 108. Latin America Daptomycin Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 109. Middle East and Africa Daptomycin Sales (K MT) and Growth Rate Forecast (2021-2026) Figure 110. Middle East and Africa Daptomycin Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 111. Asia Pacific Daptomycin Sales (K MT) and Growth Rate Forecast (2021-2026) Figure 112. Asia Pacific Daptomycin Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 113. Bottom-up and Top-down Approaches for This Report Figure 114. Data Triangulation Figure 115. Key Executives Interviewed

Merck & Co. Pfizer Teva Mylan Fresenius Kabi Sagent Pharmaceuticals Xellia Hisun HENGRUI PHARMA Huadong Medicine